WuXi AppTec

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients.

Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.

WuXi AppTec received AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that “every drug can be made and every disease can be treated.”

Address:

6 Cedarbrook Drive

Cranbury NJ 08512

Email: [email protected]

Phone number:

609-606-6666

Link to contact page: https://labtesting.wuxiapptec.com/contact-us/

Bioanalytical Services 

Small molecule solutions

Large molecule solutions

Bioanalysis of gene and cell therapeutic products in new biotechnology era

Bioanalytical applications of inductively coupled plasma mass spectrometer (ICP-MS)

Bioanalysis of antibody-drug conjugates

AAPS 2024 Pharmsci 360

Booth 1730

October 20-23

Salt Lake City, Utah

Bioanalysis in the Age of New Drug Modalities

ICH M10 Guidance: Harmonization and Modification to Bioanalytical Method Variation

WuXi “Meet Our Experts” Page